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ABSTRAK
Rabdomiosarkoma (RMS) adalah sejenis sarkoma yang biasa terdapat pada kanak-
kanak dan remaja. Penyakit ini jarang berlaku pada bayi dan menimbulkan kesukaran 
dari segi diagnosis dan perawatan selanjutnya. Di sini, kami ingin membentangkan  
kes seorang bayi yang didiagnosa sebagai rabdomiosarkoma alveolar yang 
agresif. Bayi tersebut mengalami  kebengkakkan di leher yang melibatkan tulang 
belakang dan saraf neurogenik. Pemeriksaan tisu histopatologi mendedahkan 
tumor sel berbentuk bulat dan primitif tanpa pembezaan rabdoid. Berdasarkan 
simptom klinikal dan neurologi, lokasi tumor dan histopatologi mencadangkan 
penyakit neuroblastoma pada awalnya. Walau bagaimanapun, pemeriksaan lanjut 
menunjukkan sel tumor adalah positif kepada desmin dan mempamerkan nuklear 
immunoreaktiviti kepada MyoD1 dan miogenin, yang menyokong diagnosis  
rhabdomyosarkoma. Fluorescent in situ hibridisasi mengesahkan terdapat 
translokasi t(2;13)(q35;q14) dan mengesahkan diagnosis rabdomiosarkoma alveolar. 
Pesakit menjalani kemoterapi tetapi meninggal dunia selepas dua bulan kerana 
kejutan septik. Rabdomiosarkoma adalah tumor yang amat agresif dan boleh 
membawa  kesukaran dari segi diagnostik. Kes ini menunjukkan kajian molekular 
adalah amat penting dalam membuat diagnosis yang tepat agar kemoterapi yang 
sesuai dapat dimulakan. 
Kata kunci: alveolar, bayi, FISH, rabdomiosarkoma
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Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in children 
and adolescents. The rarity of its occurrence in infant poses a great difficulty 
in terms of diagnosis and management. Here, we report an aggressive case of 
alveolar rhabdomyosarcoma in an infant who presented with neck swelling and 
neurological complications. The Magnetic Resonance Imaging (MRI) revealed 
a soft tissue swelling of the neck with intraspinal extension and spinal cord 
compression, raising the possibility of a neurogenic or malignant nerve sheath 
tumour. Histopathological examination revealed a primitive, small round cell 
tumour with no rhabdoid differentiation. The clinical presentation, neurological 
symptoms, tumor location and the histopathologic  features were highly suggestive 
of neuroblastoma. However, the tumour cells were positive for desmin with focal 
and weak nuclear positivity for myogenin and MyoD1; immunoexpressions 
which were in favour of rhabdomyosarcoma. Fluorescent in situ hybridization 
(FISH) confirmed the presence of  a translocation t(2;13)(q35;q14), supporting 
the diagnosis of alveolar rhabdomyosarcoma. Despite chemotherapy, patient 
succumbed to death after two months due to septic shock. Rhabdomyosarcoma 
is highly aggressive mesenchymal neoplasm which may present with diagnostic 
difficulty. This case highlights the importance of molecular studies in making an 
accurate diagnosis so that appropriate chemotherapy may be instituted. 
Keywords: alveolar, FISH, infant, rhabdomyosarcoma
difficult to diagnose without the help 
of immunohistochemical or molecular 
study. RMS have distinct clinical, 
pathologic and molecular differences 
which varies in clinical outcome 
and approach to therapy. The most 
prevalent subtype is embryonal 
rhabdomyosarcoma (ERMS) 
accounting for about 60% of RMS 
cases. It occurs mainly in children 
younger than 10 years associated 
with a favourable prognosis (Marshall 
et al. 2012). The alveolar subtype 
(ARMS) constitutes another 20% of 
RMS cases and occurs predominantly 
in adolescents (Marshall et al. 2012). 
ARMS are more aggressive with poorer 
prognosis. 
INTRODUCTION
Rhabdomyosarcoma (RMS), constitute 
a distinctive group of malignant 
tumours that share a tendency to 
undergo myogenesis (Parham et al. 
2006).  It is recognized as childhood 
and young adolescent malignancy. 
RMS is most frequently encountered 
soft tissue sarcoma in infant and 
children (Vankalakunti et al. 2006). 
It occurs in any sites of anatomical 
location where there is skeletal muscle 
differentiation present (Chu 2013). The 
vast majority of RMS occurs in head and 
neck region, extremities, genitourinary 
system and trunk. RMS bears variable 
histological pattern including poorly 
differentiated tumours that are very 
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CASE REPORT
A 2-month-old girl presented with 
history of reduced left hand movement 
and progressive swelling of left neck 
region for two weeks associated 
with partial ptosis of the left eye. 
Physical examination revealed a hard 
and lobulated mass at the left neck 
measuring 10 x 5 cm (Figure 1). There 
was presence of left Horner syndrome 
and lower motor neuron symptoms of 
the left upper limb. An urgent magnetic 
resonance image (MRI) of the neck and 
thorax showed a soft tissue mass at the 
left neck which was homogenous and 
multilobulated, extending from C2 to 
T5 vertebral body. Multiple enlarged 
lymph nodes at the left axillary 
region were detected. The mass 
showed intraspinal extension and 
spinal cord compression, thus raising 
the possibility of a neurogenic   or 
malignant nerve sheath tumour.  
 Histopathological examination 
of the biopsy of the mass revealed a 
primitive, small round cell tumour with 
no rhabdoid differentiation (Figure 2A). 
Based on the tumour morphology, 
the differential diagnoses include 
rhabdomyosarcoma, lymphoma, 
neuroblastoma and epithelial tumour. 
The tumour cells were positive for 
desmin with focal and weak nuclear 
Figure 1: Hard and lobulated mass at the left 
neck measuring 10 x 5 cm
Figure 2: (A) Sheets of poorly differentiated tumour cells (H&Ex400) showing positive immunostaining 
for (B) desmin; x400; (C) MyoD1 expression of weak nuclear positivity with cytoplasmic,non-specific 
background staining; (D) FISH analysis shows abnormal cells with one green, one orange and one 
fusion signal pattern.
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positivity for myogenin and MyoD1 
(Figure 2B & 2C). S100, chromogranin, 
neuron-specific enolase (NSE), 
synaptophysin, vimentin, pan-
cytokeratin and leucocyte common 
antigen (LCA) were negative. Ki67 
proliferative index was high (90%). 
The immunohistochemical studies 
were in favour of rhabdomyosarcoma. 
Further confirmation by fluorescent in 
situ hybridization (FISH) showed 
presence of translocation t(2;13)
(q35;q14), thus supporting the diagnosis 
of alveolar rhabdomyosarcoma (Figure 
2D).
 The patient's condition rapidly 
deteriorated and had to be 
ventilated.  Chemotherapy  MT95 
protocol (Strategy 953 (ARM B)) was 
commenced consisting of intravenous 
fosfamide, vincristine and actinomycin 
D. Unfortunately, the patient 
developed severe neutropenic sepsis 
and succumbed from septic shock.
DISCUSSION
The presenting signs and symptoms 
of RMS are variable and depending 
on the sites of origin of the primary 
tumour (Dagher & Helman 1999).  
The common sites include the head 
and neck, gastrointestinal, urinary 
tracts and the extremities (Parham et 
al. 2006).  Head and neck RMS can 
arise from the orbit, parameningeal 
sites, scalp, parotid glands, oral cavity, 
pharynx, thyroid, parathyroid glands 
and neck region. There are two distinct 
types of RMS, namely the embryonal 
and the alveolar subtypes. The 
diagnosis of ARMS is considered when 
the histopathologic examination of the 
tumor tissue shows undifferentiated 
small round blue tumor cells lining up 
the spaces reminiscent of pulmonary 
alveoli. RMS may display cross-
striation which is characteristic 
of skeletal or rhabdomyoblast 
differentiation (Dagher & Helman 
1999). Ancillary studies that include 
a panel of immunohistochemical 
staining need to be carried out in 
diagnosing RMS (Parham et al. 2006). 
Muscle specific protein markers 
such as alpha-actin, myogenin, 
myosin, desmin, myoglobin, Z-band 
protein and Myo-D are very useful 
(Dagher & Helman 1999). In difficult 
cases, additional molecular study is 
important to confirm the diagnosis 
and subtypes of RMS.  The majority of 
ARMS tumours carry a characteristic 
chromosomal translocations of t(2;13) 
(q35;q14) (Marshall et al. 2012). This 
chromosomal translocations produce 
an oncogenic (PAX3-FOX01) fusion 
protein and can be detected in 55% of 
ARMS cases. Another 22% of ARMS 
cases exhibit translocation of t(1;13)
(p36;q14) with characteristic  (PAX7-
FOX01) fusion oncogene proteins 
(Marshall et al. 2012). 
 In cases of small round blue cell 
tumors of the head and neck, several 
differential diagnoses need to be 
considered, which include Ewing 
sarcoma/PNET, neuroblastoma and 
lymphoma (Reshma et al. 2013).  Ewing 
sarcoma is group of highly malignant 
small round cells characterized by 
monotonous round blue cell tumour. 
It is common in children and young 
adult. Immunohistochemistry studies 
will show tumour cells positivity 
for CD99 and FLI-1expression. 
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Cytogenetic studies exhibit EWSR-
ETS fusions. It involves the EWS gene 
which also known as EWSR1 located 
on chromosome 22 and a member 
of ETS family including FLI1 and ERG 
(Pinto et al. 2011).  
 Neuroblastoma of head and neck is 
the second most common tumour after 
rhabdomyosarcoma. It can manifest as 
extracranial soft tissue tumour in infant 
less than 12 months (Sameer et al. 2017).  
The tumor originates from primitive 
neuroectodermal cells derived from 
neural crest cells. Histologically, 
it exhibits small round cells with 
features of neural or ganglionic cells 
depending on maturation and 
differentiation. Immunohistochemical 
studies show positivity for neuron 
specific enolase, synaptophysin and 
chromogranin (Reshma et al. 2013). 
Common lymphoma in paediatric 
patients include lymphoblastic 
lymphoma and Burkitt lymphoma 
and the immunohistochemistry 
studies performed, shows positivity 
for lymphoid markers. Thus, 
immunohistochemistry is very crucial 
in diagnosis of small round blue cell 
tumors to help reach to the specific 
diagnosis. Failure to give a specific 
diagnosis leads to different treatment 
modalities.
 As seen in the current case, 
alveolar rhabdomyosarcoma 
behaves aggressively. It is prone to 
metastasis and carries poor prognosis. 
Management of RMS requires 
multimodality therapeutic approach 
including surgery, chemotherapy and 
radiotherapy (El Nadi et al. 2013). 
Many authors agree that management 
of infant less than one year should 
be a tailored therapeutic approach.  
The prognosis of RMS depends on 
the grade of the tumour, age, type of 
resection, histology, translocation and 
number of sites with metastases (Eguía-
Aguilar et al. 2016). The prognosis is 
less favourable due to the physiologic 
immaturity of many organ systems in 
infants (Pinto et al. 2003).
CONCLUSION
Rhabdomyosarcoma is a highly 
aggressive mesenchymal neoplasm 
which may present with diagnostic 
difficulty. Correlation with clinical, 
radiological and histopathological 
examination along with 
immunohistochemical and molecular 
study are crucial for accurate diagnosis 
and appropriate chemotherapy.
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